Skip to content

Ultrasound to evaluate the effect of impaired vasodilation on the vasodilator effect of nitroglycerin in the perioperative period in patients with diabetes mellitus

Ultrasound to evaluate the effect of impaired vasodilation on the vasodilator effect of nitroglycerin in the perioperative period in patients with diabetes mellitus

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099965
Enrollment
Unknown
Registered
2025-04-01
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

experimental group:After extubation, the experimental group decided whether to administer the drug according to the hemodynamic parameters immediately after extubation, and all patients with hypertens
control group:After extubation, the experimental group decided whether to administer the drug according to the hemodynamic parameters immediately after extubation, and all patients with hypertension a

Sponsors

Medical ethics committee of of Shaw Hospital, Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Gastrointestinal tumor surgery; 2. Diabetes mellitus (medical history> = 5 years, oral hypoglycemic drugs or insulin injection); 3. ASA classification: II~III; 4. Age: 18~64 years old; 5BMI:18~27.9 kg/m².

Exclusion criteria

Exclusion criteria: 1. Unable to complete FMD test; 2. Difficult airway; 3. Intraoperative hemorrhage (loss of >=50% circulating blood volume within 3 h); 4. Intraoperative hemodynamic instability, use of vasoactive drugs >=3 times; 5. Baseline MAP <70 mmHg; 6. Difficulty in extubation or re-intubation after surgery; 7. Admitted to ICU after surgery; 8. Persistent hypotension after admission to PACU; 9. Patients with normal blood pressure immediately after extubation.

Design outcomes

Primary

MeasureTime frame
Nitroglycerin dosage;

Secondary

MeasureTime frame
Flow-mediated vasodilation parameters (FMD);Nitroglycerin-mediated vasodilation parameters (NID);systolic blood pressure;Diastolic blood pressure;Mean arterial pressure;Pulse oximetry;heart rate;Extubation quality score;Cardiovascular adverse events;

Countries

China

Contacts

Public ContactXiaoyu Liu

Medical ethics committee of of Shaw Hospital, Nanjing Medical University

387622981@qq.com+86 188 5601 9716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026